| Literature DB >> 36245879 |
Erin Yiqing Lu1, Andy S K Cheng1, Hector W H Tsang1, Juan Chen2, Samuel Leung2, Annie Yip3, Jessie Jingxia Lin1, Zoe Violet Lam1, Wufang Zhang4, Miaomiao Zhao4, Ning Ma4.
Abstract
Objectives: Psychoeducation, motivational interviewing, cognitive remediation training, and social skills training have been found to be effective interventions for patients with schizophrenia spectrum disorders. However, their efficacy on psychosocial functioning when provided in combination remains unclear, compared with all types of control conditions. It would also be meaningful to explore the differences of efficacy in patients with first-episode psychosis (FEP) and those with longer term of illness. Methodology: The present review followed the guidelines of Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). Full-text English journal articles of randomized controlled trials published in the past decade in the databases of PubMed, CINAHL Complete, Embase, and PsycINFO were searched. Included studies were all randomized controlled trials (RCTs) with participants diagnosed with schizophrenia spectrum disorders. The included studies should test combined interventions with at least two components from: psychoeducation, motivational interviewing, cognitive remediation training, and social skills training and incorporate assessment of psychosocial functioning at least at baseline and post-intervention.Entities:
Keywords: cognitive remediation training; first-episode psychosis; motivational interviewing; psychoeducation; schizophrenia; social skills training
Year: 2022 PMID: 36245879 PMCID: PMC9561245 DOI: 10.3389/fpsyt.2022.899840
Source DB: PubMed Journal: Front Psychiatry ISSN: 1664-0640 Impact factor: 5.435
FIGURE 1PRISMA flow diagram.
Summary of the characteristics of the included studies.
| Study | Location | Setting | Sample size for analysis | Gender | Age | Diagnosis | Illness duration | FEP |
| Valencia et al. ( | Mexico | Outpatient | I: 39 | I: 23.1% | I: 24.5 (3.0) | 100% with schizophrenia-spectrum disorders (% in subcategories unspecified) | Unspecified | Yes |
| Valencia et al. ( | Mexico | Outpatient | I: 68 | I: 26.5% | I: 29.5 (6.8) | 100% with schizophrenia-spectrum disorders (% in subcategories unspecified) | I: 8.2 (5.3) | No |
| Au et al. ( | Hong Kong SAR | Outpatient | I: 45 | I: 37.8% | I: 35.38 (9.2) | -I: Schizophrenia (64.4%); schizoaffective disorder (35.6%) | I: 11.33 (8.9) | No |
| Fisher et al. ( | The US | Outpatient | I: 57 | I: 22.8% | I: 44.08 (13.1) | -I: Schizophrenia (68.4%); schizoaffective disorder (29.8%); psychosis NOS (1.8%) | Unspecified | No |
| Inchausti et al. ( | Spain | Outpatient | I: 36 | I: 44% | I: 38.08 (12.1) | -I: Schizophrenia (50%); schizoaffective disorder (33%); delusional disorder (17%) | I: 13.4 (8.9) | No |
| Lindenmayer et al. ( | The US | Inpatient and Outpatient | I: 39 | I: 25.6% | I: 41.0 (12.1) | -I: Schizophrenia (79.5%); schizoaffective disorder (2.1%) | I: 14.34 (8.89) | No |
| Matsuda et al. ( | Japan | Outpatient | I: 31 | I: 45.2% | I: 36.4 (8.5) | 100% with schizophrenia-spectrum disorders (% in subcategories unspecified) | Unspecified | No |
C, control group; FEP, first-episode psychosis; I, intervention group; psychosis NOS, psychosis not otherwise specified; SD, standard deviation.
Summary of the interventions, controls, and outcomes of the included studies.
| Study | Intervention duration | Details of relevant treatment component(s) | Other treatment components | Controls | Relevant | Results |
| Valencia et al. ( | 1 year | (1) Psychosocial functioning (GAF) | ||||
| Valencia et al. ( | 6 months | (1) Psychosocial functioning (GAF) | ||||
| Au et al. ( | 3 months | (1) Psychosocial functioning (GAF) | ||||
| (3) No significant group differences in cognitive function except for learning; intervention group had significantly higher score in learning. | ||||||
| Fisher et al. ( | 14 weeks | NA | (1) Psychosocial functioning (Social Functioning Scale) | |||
| Inchausti et al. ( | 16 weeks | NA | (1) Psychosocial functioning (Social and Occupational Functioning | |||
| Lindenmayer et al. ( | 12 weeks | (1) Psychosocial functioning (Personal and Social Performance Scale) | ||||
| Matsuda et al. ( | 12 weeks | (1) Psychosocial functioning (Life Assessment Scale for Mentally Ill) | ||||
BPRS, brief psychiatric rating scale; GAF, global assessment of functioning scale; IPS, individual placement and support; NA, not applicable; NCT, neurocognitive training; PANSS, positive and negative syndrome scale; PE, psychoeducation; SCT, social cognition training; MCT, metacognition training; SST, social skills training; TAU, treatment as usual.
FIGURE 2Risk of bias.
FIGURE 3Forest plot of psychosocial functioning.
Meta-analyses of the effects at post-intervention on psychosocial functioning (primary outcome).
| Included studies | Sample ( | Total mean difference (95% CI) |
|
| Heterogeneity |
| All the included studies: | I: 255 | SMD = 1.03 | 2.09 | 0.04 | τ2 = 1.39 |
| Studies working with non-FEP participants: | I: 216 | SMD = 0.80 | 1.53 | 0.13 | τ2 = 1.32 |
| Studies testing the effects relative to control conditions with one less intervention component: | I: 148 | SMD = 0.29 | 1.16 | 0.24 | τ2 = 0.18 |
FEP, first-episode psychosis; PE, psychoeducation; SST, social skills training; TAU, treatment as usual; I, intervention group; C, control group; SMD, standard mean difference; MD, mean difference.
Meta-analyses of the effects at post-intervention on secondary outcomes.
| Outcome | Included studies | Sample ( | Total mean difference |
|
| Heterogeneity |
| Positive symptoms | Valencia et al. ( | I: 210 | 0.36 | 0.72 | τ2 = 2.12 | |
| Negative symptoms | Valencia et al. ( | I: 210 | 1.02 | 0.31 | τ2 = 6.70 | |
| General psychopathology | Valencia et al. ( | I: 103 | 0.58 | 0.57 | τ2 = 22.29 | |
| Overall score of symptom severity | Valencia et al. ( | I: 187 | SMD = 0.22 | 0.51 | 0.61 | τ2 = 0.92 |
| Speed of processing | Au et al. ( | I: 113 | 1.02 | 0.31 | τ2 = 9.98 | |
| Visual learning | Au et al. ( | I: 113 | 1.06 | 0.29 | τ2 = 2.67 | |
| Reasoning and problem solving | Au et al. ( | I: 113 | MD = –0.42 | 0.39 | 0.69 | τ2 = 1.73 |
| Attention/vigilance | Au et al. ( | I: 113 | 0.23 | 0.82 | τ2 = 14.38 |
I, intervention group; C, control group; SMD, standard mean difference; MD, mean difference.